NovaBridge Biosciences (NBP)
1.02
-0.05
(-4.67%)
USD |
NASDAQ |
Nov 03, 14:20
NovaBridge Biosciences Total Assets (Quarterly) : 260.52M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | 260.52M |
| September 30, 2025 | 277.41M |
| June 30, 2025 | 206.71M |
| March 31, 2025 | 208.94M |
| December 31, 2020 | 968.50M |
| Date | Value |
|---|---|
| September 30, 2020 | 631.09M |
| December 31, 2019 | 249.45M |
| September 30, 2019 | 257.71M |
| December 31, 2018 | 346.06M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Xencor, Inc. | 724.96M |
| Arrivent BioPharma, Inc. | 394.72M |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 7.995B |
| Anika Therapeutics, Inc. | 183.47M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 29.58M |
| Shareholders Equity (Quarterly) | 230.94M |